| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |